I was listening to a podcast the other day and it was saying that some people are or might be more predisposed to being susceptible to placebos than others - something to do with a variation of a gene related to dopamine release. If this is the case, how would it affect drug trials? Would people highly susceptible to placebos skew a drug trial and make the drug seem less effective?
via JREF Forum http://ift.tt/1pVMZoq
Aucun commentaire:
Enregistrer un commentaire